Difference between revisions of "Team:CGU Taiwan/Achievements"

Line 387: Line 387:
 
<li><a href="http://parts.igem.org/Part:BBa_K1955000">BBa_K1955000</a>, hemagglutinin of H1N1, is useful for further immunology study.</li>
 
<li><a href="http://parts.igem.org/Part:BBa_K1955000">BBa_K1955000</a>, hemagglutinin of H1N1, is useful for further immunology study.</li>
 
<li>Our collaborations are listed <a href="https://2016.igem.org/Team:CGU_Taiwan/Collaborations">here</a>.</li>
 
<li>Our collaborations are listed <a href="https://2016.igem.org/Team:CGU_Taiwan/Collaborations">here</a>.</li>
<li>We participated in many activities such as <a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices">educational event, surveying the general public and visiting organizations</a>.</li>
+
<li>We participated in many activities such as <a href="https://2016.igem.org/Team:CGU_Taiwan/Human_Practices">educational events, surveying the general public and visiting organizations</a>.</li>
 
</ul>
 
</ul>
 
</div>
 
</div>

Revision as of 04:19, 2 December 2016


Achievement













  • We discussed multiple issues of our product and improved our project after carrying out the survey and communication for our integrated human practices.
  • The proof of concept shows the results of our project and value of our product.
  • We demonstrate our project with our prediction platform which could apply in the real world.